Fibrate Compounds Having Ppar Agonist Activity
    21.
    发明申请
    Fibrate Compounds Having Ppar Agonist Activity 审中-公开
    具有Ppar激动剂活性的纤维化合物

    公开(公告)号:US20080114005A1

    公开(公告)日:2008-05-15

    申请号:US11574702

    申请日:2005-09-06

    IPC分类号: A61K31/519 C07D487/02

    CPC分类号: C07D487/04 C07D239/90

    摘要: There are provided derivatives having PPAR agonist activity. The derivatives include compounds and/or their pharmaceutically acceptable salts; the compounds having the formula (I) wherein A has the structure (II) or (III); X is chosen from —CH2—, —O—, —NH—, and —S—; Y is chosen from —O—, —NH—, and —S—; Z, which may be located in any position of substitution, is hydrogen or halogen; R1 and R2, which may be the same or different, are independently chosen from hydrogen and C1-C8 alkyl, or R1 and R2 together form a carbocyclic ring having from 4 to 6 carbon atoms; R3 is chosen from hydrogen and C1-C8 alkyl; R4, R5, and R6, which may be the same or different, are independently chosen from hydrogen and C1-C8 alkyl; and n is 1 to 6. Various embodiments and variants are provided. In accordance with other aspects, the invention also provides methods of producing a PPARα agonist activity in a mammal, the methods including administering to the mammal an effective amount of certain derivative(s) of the first aspect of the invention, a method of producing a PPARα agonist activity and a PPARα agonist activity in a mammal, the method including administering to the mammal an effective amount of certain derivative(s); and a pharmaceutical composition that includes the derivative(s) of the first aspect of the invention and one or more pharmaceutically-acceptable excipients. Various embodiments and variants are provided.

    摘要翻译: 提供具有PPAR激动剂活性的衍生物。 衍生物包括化合物和/或其药学上可接受的盐; 具有式(I)的化合物其中A具有结构(II)或(III); X选自-CH 2 - , - O - , - N - 和-S-; Y选自-O - , - NH-和-S-; 可以位于任何取代位置的Z是氢或卤素; R 1和R 2可以相同或不同,独立地选自氢和C 1 -C 8烷基, 或者R 1和R 2一起形成具有4至6个碳原子的碳环; R 3选自氢和C 1 -C 8烷基; R 4,R 5,R 5和R 6可以相同或不同,独立地选自氢和C 1 C 8 -C 14烷基; 并且n为1至6.提供了各种实施方案和变体。 根据其它方面,本发明还提供了在哺乳动物中产生PPARα激动剂活性的方法,所述方法包括向哺乳动物施用有效量的本发明第一方面的某些衍生物, PPARα激动剂活性和哺乳动物中的PPARα激动剂活性,所述方法包括向哺乳动物施用有效量的某些衍生物; 和包含本发明第一方面的衍生物和一种或多种药学上可接受的赋形剂的药物组合物。 提供了各种实施例和变型。